Borbulevych, O. Y., Baxter, T. K., Yu, Z., Restifo, N. P., & Baker, B. M. (2005). Increased Immunogenicity of an Anchor-Modified Tumor-Associated Antigen Is Due to the Enhanced Stability of the Peptide/MHC Complex: Implications for Vaccine Design.

Borbulevych, Oleg Y., Tiffany K. Baxter, Zhiya Yu, Nicholas P. Restifo, and Brian M. Baker. Increased Immunogenicity of an Anchor-Modified Tumor-Associated Antigen Is Due to the Enhanced Stability of the Peptide/MHC Complex: Implications for Vaccine Design. 2005.

Borbulevych, Oleg Y., et al. Increased Immunogenicity of an Anchor-Modified Tumor-Associated Antigen Is Due to the Enhanced Stability of the Peptide/MHC Complex: Implications for Vaccine Design. 2005.